Technical note: Digital quantification of eye pigmentation of cattle with white faces.

Cancer of the eye in cattle with white faces occurs less frequently in cattle with pigmented eyelids. Corneoscleral pigmentation is related to eyelid pigmentation and occurrence of lesions that may precede cancer. Objectives of this study were to assess 1) variation in the proportion of eyelid and corneoscleral pigmentation in Hereford, Bos taurus, and Bos indicus crossbreds and 2) the occurrence of lesions with the presence of pigmentation in those areas. Hereford and Bos indicus crosses (Brahman or Nellore with Angus and Hereford and straightbred Brafords) and Bos taurus crosses (Angus-Hereford) were included in the study (n = 1,083). Eyelid pigmentation proportions were estimated by pixel quantification and were evaluated as total proportions and for upper and lower eyelids distinctly for each eye. Fixed effects included breed type, age categories, and sex of the animal. Lesion presence (1) or absence (0) was obtained by visual appraisal of image and was assumed to be binomially distributed. Eyelid pigmentation proportions (overall, upper, and lower eyelids) for Hereford ranged from 0.65 ± 0.03 to 0.68 ± 0.03 and were significantly lower than Bos indicus (range from 0.93 ± 0.02 to 0.95 ± 0.02) or Bos taurus (ranged from 0.88 ± 0.02 to 0.92 ± 0.02) crosses. Corneoscleral pigmentation in Hereford cows (0.17 ± 0.06) did not differ (P = 0.91) from Hereford calves and yearlings (0.16 ± 0.07). Bos indicus and Bos taurus crossbred cows had larger corneoscleral pigmentation (0.38 ± 0.05 and 0.48 ± 0.04 for left eyes and 0.37 ± 0.05 and 0.53 ± 0.04 for right eyes, respectively) than all calves (P < 0.001), and their corneoscleral pigmentations were greater than that of Hereford cows (P < 0.003). Bos indicus and Bos taurus cows had greater proportions of left eye corneoscleral pigmentation (0.38 ± 0.05 and 0.48 ± 0.04, respectively) than Hereford cows (0.17 ± 0.06) and all young animal breed types (P < 0.05). Right eye proportions differed for all cow groups (P < 0.05; 0.53 ± 0.04, 0.37 ± 0.05, and 0.17 ± 0.06). Among calves and yearlings, Hereford had a lower right eye corneoscleral pigmentation proportion (0.16 ± 0.07) than Bos taurus (P = 0.02). The lesion proportion for Hereford (0.08 ± 0.03) was significantly greater than that of either Bos indicus (0.01 ± 0.005) or Bos taurus (0.01 ± 0.003). Crossbreeding with Bos taurus or Bos indicus animals appears to increase eye pigmentation, which may help reduce the occurrence of cancer in eyes of cattle with white faces.

Effects of rumen-protected polyunsaturated fatty acid supplementation on performance and physiological responses of growing cattle after transportation and feedlot entry.

Two experiments were conducted to evaluate the effects of rumen-protected PUFA supplementation on performance and inflammation measures in beef calves after truck transportation and feedyard entry. In Exp. 1, 30 weaned Braford steers (BW = 218 ± 4.3 kg) were transported for 1,600 km over a 24-h period in a commercial trailer and delivered to a feedlot (d 0). Upon arrival (d 1), steers were stratified by BW and allocated to receive 1 of 3 treatments (10 steers/treatment), which consisted of grain-based concentrates without supplemental fat (NF), or with the inclusion of a rumen-protected SFA (SF; 2.1% as-fed basis) or PUFA source (PF; 2.5% as-fed basis). Shrunk BW was determined on d 1 and 30 for ADG calculation. Individual DMI was recorded from d 2 to 28. Blood samples were collected on d 0, 1, 4, 8, 15, 22, and 29 for determination of acute-phase protein concentrations. Steers fed PF had decreased (P = 0.04) mean DMI and tended to have reduced ADG (P = 0.07) compared with NF-fed steers (2.32 vs. 2.72% of BW, and 0.78 vs. 1.07 kg/d, respectively). No other treatment effects were detected. In Exp. 2, 48 weaned Brahman-crossbred heifers (BW = 276 ± 4.6 kg) were stratified by initial BW and randomly allocated to 6 pastures (8 heifers/pasture) before transportation (d -30 to 0). Pastures were randomly assigned (3 pastures/treatment) to receive (DM basis) 3.0 kg/heifer daily of NF, or 2.5 kg/heifer daily of a concentrate containing 5.7% (as-fed basis) of a rumen-protected PUFA source (PF). On d 0, heifers were transported as in Exp. 1. Upon arrival (d 1), 24 heifers were randomly selected (12 heifers/treatment), placed into individual feeding pens, and assigned the same pretransport treatment. Shrunk BW was recorded on d -30, 1, and 30 to determine ADG. Individual DMI was recorded daily from d 2 to 28. Blood samples were collected on d 0, 1, 4, 8, 15, 22, and 29 for determination of acute-phase protein concentrations. A treatment × day interaction was detected for haptoglobin (P < 0.01) because PF-fed heifers had decreased haptoglobin concentrations compared with NF-fed heifers on d 1, 4, and 8. No other treatment effects were detected. Data from this study indicate that PUFA reduces haptoglobin concentrations in beef calves after transport and feedlot entry when supplemented before and after transportation. Further, PUFA supplementation during the feedyard only appears to negatively affect cattle performance by decreasing ADG and DMI.

Effect of dietary cation-anion difference on measures of acid-base physiology and performance in beef cattle.

Dietary constituents can affect cow acid-base physiology and uterine pH. Dietary cation-anion difference (DCAD) has been shown to affect cow acid-base physiology, but the effect on uterine pH has not been demonstrated. The objective of this work was to determine if DCAD [(Na + K + 0.15Ca + 0.15Mg) - (Cl + 0.60S + 0.50P)] could affect cow DMI, acid-base physiology, and uterine pH, and second, to determine if dietary supplements could alleviate any negative effects of DCAD on these variables. In Exp. 1, 21 cows were utilized to determine the effect of a negative DCAD (-0.9 mEq/100 g of DM; low-DCAD) or positive DCAD (+25.0 mEq/100 g of DM; high-DCAD) diet on cow BW, DMI, and pH of blood, urine, and uterine flush fluid. In Exp. 2, 21 cows were randomly allotted to 1 of 3 treatments: control (-3.1 mEq/100 g of DM), molasses (+2.9 mEq/100 g of DM), or molasses+buffer (+25.8 mEq/100 g of DM) to determine if supplemental liquid molasses or liquid molasses with a buffer could alleviate the effects of a negative DCAD, forage-based diet. Cows were individually fed their respective diets for 42 d in both experiments. Cow BW, blood, urine, and uterine flush were collected on d 0, 21, and 42 during both experiments. Cow ADG was not different (P = 0.71) in Exp. 1 or Exp. 2 (P = 0.47). Hay DMI did not differ (P < 0.70) between high-DCAD and low-DCAD cows before d 28, but was greater (P < 0.001) for high-DCAD cows after d 28 in Exp. 1. In Exp. 2, mean hay DMI did not differ (P = 0.39) among treatments. In Exp. 1, a treatment x day interaction (P < 0.05) was apparent for blood, pH, base excess, bicarbonate, pCO(2), and urine pH. Blood gas and pH measures peaked on d 21 for high-DCAD and declined from d 0 to 42 in low-DCAD cows. High-DCAD cows had greater (P = 0.08) uterine flush pH compared with low-DCAD cows. In contrast, during Exp. 2 there were no differences (P > 0.14) among treatments for blood, pH, base excess, pCO(2), or uterine flush pH. Urine pH exhibited a treatment x day interaction (P < 0.0001). On d 21 molasses supplemented cow urine pH was greater (P < 0.0001) than control cows, whereas on d 42 molasses+buffer had greater (P = 0.01) urine pH compared with control and molasses cows. Dietary cation-anion difference and the use of molasses-based supplements had minimal effect on forage-fed beef cow DMI. However, DCAD has the capacity to alter forage-fed beef cow acid-base physiology and potentially affect uterine physiology.

Effect of breed composition on phenotypic residual feed intake and growth in Angus, Brahman, and Angus x Brahman crossbred cattle.

The influence of additive and nonadditive genetic effects and temperament on 4 postweaning feed intake and growth traits was evaluated in a group of 581 bull, heifer, and steer calves born in 3 Florida herds in 2006 and 2007. Calves had breed compositions ranging from 100% Angus (A) to 100% Brahman (B). They were randomly allocated to 24 pens each year by herd (Brooksville, Gainesville, Marianna, FL), sire group (A, 3/4 A 1/4 B, Brangus, 1/2 A 1/2 B, 1/4 A 3/4 B, and B), and sex (bull, heifer, and steer) in a GrowSafe automated feeding facility at Marianna. Calves were fed a concentrate diet during the 21-d adjustment and the 70-d trial periods. Individual feed intakes were recorded daily, and BW, chute scores, and exit velocities were recorded every 2 wk. Traits were phenotypic daily residual feed intake (RFI), mean daily feed intake (DFI), mean daily feed conversion ratio (FCR), and postweaning BW gain. Phenotypic RFI was computed as the difference between actual and expected feed intakes. Calves were assigned to 3 RFI groups: high (RFI greater than 0.9 kg of DM/d), low (RFI less than -0.9 kg of DM/d), and medium (RFI between mean +/- 0.9 kg of DM/d; SD = 1.8 kg of DM/d). The mixed model included the fixed effects of contemporary group (herd-year-pen), RFI group (except when trait was RFI), age of dam, sex of calf, age of calf, B fraction of calf, heterozygosity of calf, mean chute score, and mean exit velocity. Brahman fraction and heterozygosity of calf were nested within sex of calf for RFI and within RFI group for DFI, FCR, and postweaning BW gain. Random effects were sire and residual. Feed efficiency tended to improve (decreased RFI) as the B fraction increased. However, calves required larger amounts of feed per kilogram of BW gain (larger FCR) as the B fraction increased. Postweaning BW gain tended to decrease as the B fraction increased. Temperament traits were unimportant for all traits except exit velocity for DFI, suggesting perhaps a lack of variation for temperament traits in this herd, or that calves became accustomed to the level of handling pre- and postweaning, thus decreasing behavioral differences among them.

Influence of a CIDR prior to bull breeding on pregnancy rates and subsequent calving distribution.

We determined whether insertion of a CIDR for 7 days prior to the breeding season enhanced pregnancy rates and altered the date of conception in suckled beef cows mated naturally. Suckled beef cows (n=2033) from 15 locations were randomly assigned to one of two treatments: (1) cows received a CIDR 7 days prior to the breeding season for 7 days (CIDR; n=999); (2) cows received no treatment (Control; n=1034). On the first day of the breeding season bulls were introduced to herds at a rate of 15-25 cows per yearling bull or 20-30 cows per mature bull. Pregnancy status and the date of conception were determined via transrectal ultrasonography at 56 and 120 days after initiation of the breeding season. Overall pregnancy rates ranged from 59.3 to 98.9% among the 15 locations. The percentage of cows becoming pregnant during the first 30 days of the breeding season was similar between CIDR (68.2%) and Control (66.7%) cows, and overall pregnancy rates were similar between CIDR (88.9%) and Control (88.6%) cows. The average day of conception after initiation of the breeding season was shorter (P<0.01) for CIDR (20.1+/-0.8 days) compared to Control cows (23.2+/-0.8 days). Of cows conceiving during the breeding season, more (P<0.05) CIDR cows (35.9%) conceived during the first 10 days of the breeding season than Control cows (30.8%). Neither body condition score and nor parity affected pregnancy rates or days to conception, whereas pregnancy rates and days to conception were affected (P<0.01) by location and days postpartum. Days to conception were greater for cows that calved within 40 days (31.6+/-1.2 days) of initiation of the breeding season compared to cows calving between 40 and 50 days (25.3+/-1.2 days) prior to initiation of the breeding season, which were greater than those cows calving between 50-60 days (20.0+/-0.8 days) and 60-70 days (21.3+/-1.0 days) prior to initiation of the breeding season. Cows calving greater than 70 days (17.3+/-1.5 days) from initiation of the breeding season had the shortest interval to conception. We concluded that insertion of a CIDR prior to the breeding season failed to increase overall pregnancy rates, but did influence the average day of conception.

Assignment of six genes to bovine chromosomes 5 and 16 by fluorescence in situ hybridization, radiation hybrid mapping and genetic linkage analysis.

Several quantitative trait loci for beef carcass traits have been mapped to bovine chromosome 5. The objective of this study was to map six candidate genes for these traits by fluoresence in situ hybridization, genetic linkage analysis and radiation hybrid mapping. MYF5 and MYF6 were assigned to 5q13, WIF1 to 5q23 and MMP19 to 5q25. A paralog of MYF5 (putatively MYOG) was assigned to 16q12. A novel microsatellite placed MYF5 and MYF6 10.4 cM from BM6026 and 19.1 cM from BL23 on the genetic linkage map. MYF5 (62.6 cR), WNT10B (319.5 cR), WIF1 (500.8 cR) and MMP19 (701.2 cR) were also integrated into the 5000(Rad) radiation hybrid map.

An outbreak of Campylobacter jejuni infections associated with food handler contamination: the use of pulsed-field gel electrophoresis.

In 1998, an outbreak of Campylobacter jejuni infections occurred in Kansas among persons attending a school luncheon; community cases were also reported. In a cohort study of luncheon attendees, 27 (17%) of 161 persons reported illness. Consuming gravy (relative risk [RR], 4.2; 95% confidence interval [CI], 1.5-11.7) or pineapple (RR, 2.4; 95% CI, 1.0-5.7) was associated with illness. Both foods were prepared in a kitchen that served 6 other schools where no illness was reported. A cafeteria worker at the luncheon had a diarrheal illness and was the likely source of the outbreak. The pulsed-field gel electrophoresis (PFGE) patterns of the isolates from the food handler and those of 8 lunch attendees were indistinguishable. Isolates from 4 community patients differed. This was the first use of PFGE in a Campylobacter outbreak in the United States; its use was critical in determining that community cases were not linked.

The incubation period of hantavirus pulmonary syndrome.

In 1993 Sin Nombre virus was recognized as the cause of hantavirus pulmonary syndrome (HPS) and the deer mouse (Peromyscus maniculatus) was identified as the reservoir host. Surveillance by the Centers for Disease Control and Prevention and state health departments includes investigation to determine the likely site(s) and activities that led to infection, an environmental assessment of the home and workplace, and possibly rodent trappings at these sites. As of December 31, 1998, there were 200 confirmed cases from 30 states (43% case-fatality ratio). The national HPS case registry was examined to determine the incubation period of HPS. Review of 11 case-patients with well-defined and isolated exposure to rodents suggests that the incubation period of HPS is 9 to 33 days, with a median of 14-17 days. Case investigations allow a better understanding of the incubation time of HPS and may define high-risk behaviors that can be targeted for intervention.

Brucellosis induced by RB51 vaccine in a pregnant heifer.

Brucellosis developed in a 14.5-month-old Gelbvieh heifer after the animal was vaccinated with the calfhood dose of strain RB51 Brucella abortus vaccine s.c. during the fourth month of its first pregnancy. The heifer experienced dystocia and was euthanatized during cesarean section because of a large uterine tear. The fetus was dead at delivery. Suppurative placentitis and fetal pneumonia were evident at necropsy. Brucella abortus strain RB51 was isolated from the placenta and the fetus' lung.

Loratadine in the high performance aerospace environment.

BACKGROUND: Authors have unanimously reported that 10 mg of loratadine does not produce sedation. A small risk of sedation may exist and may not have been discovered by those studies due to their small sample size. HYPOTHESIS: Using combined data, there is no increased risk of sedation over placebo for patients using 10 mg of loratadine daily. METHODS: Literature search and meta-analysis of published data was performed. RESULTS: Pooled data showed sedation in 25 of 517 patients given 10 mg of loratadine, and 24 of 510 patients given placebo. The relative risk was 1.03, with a confidence interval from 0.59 to 1.77. Sleepiness was objectively studied using the multiple sleep latency test. Patients treated with 10 mg of loratadine did not have excess sleepiness induced; patients treated with 40 mg of loratadine did. Using 10 different methods, 20 studies did not find performance impairment in subjects given 10 mg of loratadine. Two performance studies, digit substitution and driving, showed impairment with 20 mg and 40 mg of loratadine, respectively. Physiologic studies using resting EEG had conflicting reports. There was no impairment detected in altitude studies or vestibular studies. No centrifuge or color vision data were found. CONCLUSION: Ingesting 10 mg of loratadine daily does not have sedative effects or impair cognitive-motor performance. Higher doses have demonstrated impairment. Aviation concerns that have not been addressed include centrifuge studies and color vision studies. It would be reasonable to employ loratadine in the high performance aerospace environment if these latter tests prove to be negative.

The relationship between fatigue, psychological and immunological variables in acute infectious illness.

OBJECTIVE: The aim of this paper is to explore the longitudinal relationships between physical and psychological symptoms and immunological factors following acute infective illnesses. METHOD: Preliminary data from a prospective investigation of patients with serologically proven acute infectious illnesses due to Epstein-Barr virus (EBV), Ross River virus (RRV) or Q fever are reported. Patients were assessed within 4 weeks of onset of symptoms and then reviewed 2 and 4 weeks later. Physical illness data were collected at interview. Psychological and somatic symptom profiles were assessed by standardised self-report questionnaires. Cell-mediated immune (CMI) function was assessed by measurement of delayed-type hypersensitivity (DTH) skin responses. RESULTS: Thirty patients who had been assessed and followed over the 4-week period (including 17 patients with EBV, five with RRV and eight with Q fever) were included in this analysis. During the acute phase, profound fatigue and malaise were the most common symptoms. Classical depressive and anxiety symptoms were not prominent. Initially, 46% of cases had no DTH skin response (i.e. cutaneous anergy) indicative of impaired cellular immunity. Over the 4-week period, there was a marked improvement in both somatic and psychological symptoms, although fatigue remained a prominent feature in 63% of subjects. The reduction in reported fatigue was correlated with improvement in the DTH skin response (p = 0.001) and with improvement in General Health Questionnaire (GHQ) scores (p < 0.01). CONCLUSIONS: Acute infectious illnesses are accompanied by a range of nonspecific somatic and psychological symptoms, particularly fatigue and malaise rather than anxiety and depression. Although improvement in several symptoms occurs rapidly, fatigue commonly remains a prominent complaint at 4 weeks. Resolution of fatigue is associated with improvement in cell-mediated immunity.

Monitoring of ajmaline in plasma with high-performance liquid chromatography.

A rapid, reliable and sensitive assay for routine determination of ajmaline in plasma by high-performance liquid chromatography with fluorimetric detection is presented. A low limit of detection in plasma (less than 1 ng/ml ajmaline) could be achieved by the extraction of plasma samples and the use of fluorimetric detection. Deproteinization of the plasma sample instead of extraction, or the use of an ultraviolet detector, yielded a higher limit of detection (less than 50 ng/ml). Two different eluents were studied. Eluent 1 allowed clear separation of ajmaline from isoajmaline and sandwicine, but did not separate isoajamaline from sandwicine. With eluent 2, separation of isoajmaline and sandwicine was achieved, but separation of ajmaline from sandwicine was less optimal than with eluent 1. Therefore, eluent 1 was used for further clinical studies. No interference was observed from therapeutic doses of other commonly co-administered drugs, such as acetylsalicylic acid, digoxin, digitoxin, ranitidine, dopamine, dobutamine, furosemide, captopril or glycerol trinitrate. In addition, the chemical stability of ajmaline and a possible rearrangement of ajmaline to its stereoisomers isoajmaline and sandwicine was studied in vivo and in vitro. Ajmaline proved to be unusually stable under both in vivo and in vitro conditions.